Skip to main content
. 2020 Nov 5;11:469. doi: 10.1186/s13287-020-01982-3

Fig. 5.

Fig. 5

Summarized diagram proposing that IGFBPs secreting PD-MSCsPRL-1 are the key antiadipogenic factors inhibiting adipogenesis in OFs from GO patients through upregulation of FAK and downregulation of the PI3K/AKT/mTOR signaling pathway